AEMD READ THE FULL AEMD RESEARCH REPORT AEMD CMO will present data on Hemopurifier potential in Long Covid at Keystone ...

KRAKOW, Poland I June 12, 2025 I Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that ...

Learn how to create and customize stunning Contact Posters on your iPhone with this step-by-step guide. Eveything you need to ...

Aethlon Medical's Hemopurifier® is an investigational extracorporeal device designed to bind and remove harmful EVs from the ...

today announces that it will have a poster presentation on 303 Study, the investigator-initiated study supported by Merck (known as MSD outside of the United States and Canada) and BeyondSpring in ...

Poster 1040: Preclinical Efficacy and Potency ... To improve AAV packaging and thus convey manufacturing benefits, we reduced the size of the original hUPF1 construct by 1.5kb while improving ...

today announced the Company will exhibit four poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, which is being held from May 13-17, 2025 ...

Adding to the immersive experience, the newly released poster specifically highlights the D-Box cinema presentation. For those seeking to truly soar with the dragons, D-Box theaters offer motion ...

Zentalis Pharmaceuticals, Inc. announced that an abstract has been accepted for a poster presentation at the 2025 American Society of Clinical Oncology Annual Meeting, scheduled for May 30 to June ...

Abstract and poster presentation details are below: Title: “Phase 1 dose escalation results of the WEE1 inhibitor, azenosertib, in combination with encorafenib and cetuximab in patients with ...